EHA24: Danish LBA Shows that Oral Vitamin C Might Improve OS for Patients with Early-Stage Myeloid Malignancies and Precursor Conditions

A Late-Breaking Abstract presented at EHA 2024 by Dr. Stine Ulrik Mikkelsen from Rigshospitalet, Denmark, shows that vitamin C supplementation has shown significant promise for improving survival in patients with low-risk myeloid malignancies and precursor conditions.